Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-24-025309
Filing Date
2024-10-07
Accepted
2024-10-07 19:08:27
Documents
2
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1945
2 POWER OF ATTORNEY (PUBLIC): POA doc1.txt EX-24 4031
  Complete submission text file 0001127602-24-025309.txt   7678
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O BIOGEN INC. 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address
Minor Lloyd (Reporting) CIK: 0002038687 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19311 | Film No.: 241358914